Fitting marginal structural and G-estimation models under complex treatment patterns: investigating the association between de novo vitamin D supplement use post breast cancer diagnosis and all-cause mortality using linked pharmacy claim and registry data.
Studies have shown that accounting for time-varying confounding through time-dependent Cox proportional hazard (PH) models may provide biased estimates of the causal effect of treatment when the confounder is also a mediator. We explore two alternative approaches to addressing this problem while examining the association between vitamin D supplementation initiated after breast cancer diagnosis and all-cause mortality. Women (50-80 y) were identified on the National Cancer Registry Ireland (n=5417) between 2001 and 2011. Vitamin D use was identified from linked prescription data (n=2581). We sought to account for the time-varying nature of vitamin D use and the time-varying confounding by bisphosphonate use using (i) marginal structural models (MSMs) and (ii) g-estimation of structural nested accelerated failure-time models (SNAFTMs). Using standard adjusted Cox PH models we found a reduction in all-cause mortality in de novo vitamin D users compared to non-users (HR = 0.84 (95% CI: 0.73, 0.99)). Additional adjustment for vitamin D and bisphosphonate use in the previous month reduced the HR (0.45 (95% CI: 0.33, 0.63)). MSM (HR = 0.44 (95% CI: 0.32, 0.61)) and SNAFTM (HR = 0.45 (95%CI: 0.34, 0.52)) results were similar. Utilising MSM and SNAFTM to account for time-varying bisphosphonate use did not alter conclusions in this example.